Cas No.: | 776309-04-7 |
Chemical Name: | N-((5-(tert-butyl)thiazol-2-yl)methyl)-N-((4-(4-((4-(heptan-4-yl)phenoxy)methyl)phenyl)thiazol-2-yl)methyl)glycine |
Synonyms: | JTT551;JTT 551 |
SMILES: | C(O)(=O)CN(CC1=NC=C(C(C)(C)C)S1)CC1=NC(C2=CC=C(COC3=CC=C(C(CCC)CCC)C=C3)C=C2)=CS1 |
Formula: | C34H43N3O3S2 |
M.Wt: | 605.86 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | JTT-551 (JTT551, JTT 551) is a novel potent, selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) with Ki of 0.22 uM, displays >45-fold and >136-fold selectivity over TCPTP, CD45 and LAR; JTT-551 exhibits clear selectivity against the other PTPs, increases the insulin-stimulated glucose uptake in L6 cells; enhances the IR phosphorylation of liver and reduces the glucose level in ob/ob mice , also shows a hypoglycaemic effect without an acceleration of body weight gain in db/db mice. |